Biotech

All Articles

Addex supply climbs after Indivior provides to $300M for substance

.Indivior is picking up a small particle allosteric modulator designed to deal with compound make us...

Molecular Allies modifies AML test over 'suboptimal exposure'

.Molecular Companions has recognized "suboptimal visibility" to its tetra-specific T-cell engager as...

Despite blended market, a venture capital resurgence might be coming in Europe: PitchBook

.While the biotech investment performance in Europe has slowed relatively following a COVID-19 backi...

8 months after a $213M fundraise, gene editor Tome produces cuts

.After increasing $213 thousand in 2023-- among the year's most extensive private biotech rounds-- V...

BioMarin develops exec crew along with biotech vets-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our roundup of notable leadership hirings, firings and re...

Biopharma Q2 VC hit highest degree considering that '22, while M&ampA reduced

.Equity capital financing into biopharma cheered $9.2 billion across 215 sell the 2nd one-fourth of ...

Bicara, Zenas look for IPOs to press late-phase assets toward market

.Bicara Rehabs and also Zenas Biopharma have actually offered new motivation to the IPO market along...

Genentech to close cancer immunology investigation division

.Genentech will definitely shut its cancer immunology investigation department, as well as system he...

Kezar loses strong growth however to verify its really worth in stage 1 trial

.Kezar Life Sciences is falling its dim stage 1 solid growth medication as the biotech goes all-in o...

Acelyrin loses izokibep, drops 3rd of team

.Regardless of izokibep keeping its newly found winning streak in the medical clinic, Acelyrin is no...